{"id":76361,"date":"2026-07-21T12:56:27","date_gmt":"2026-07-21T17:56:27","guid":{"rendered":"https:\/\/news2shorts.com\/index.php\/2026\/07\/21\/ozempic-maker-novo-nordisk-sues-us-rival-over-materially-misleading-ads\/"},"modified":"2026-07-21T12:56:27","modified_gmt":"2026-07-21T17:56:27","slug":"ozempic-maker-novo-nordisk-sues-us-rival-over-materially-misleading-ads","status":"publish","type":"post","link":"https:\/\/news2shorts.com\/index.php\/2026\/07\/21\/ozempic-maker-novo-nordisk-sues-us-rival-over-materially-misleading-ads\/","title":{"rendered":"Ozempic maker Novo Nordisk sues US rival over \u2018materially misleading\u2019 ads"},"content":{"rendered":"<p>Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective<\/p>\n<p>Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over \u201cfalse and materially misleading\u201d adverts for its competing weight-loss and anti-diabetes treatments.<\/p>\n<p>The Danish pharmaceuticals heavyweight complained that the US group \u2013 which makes rival weight-loss treatments Zepbound and Mounjaro \u2013 \u201cintentionally selected outdated studies\u201d that compared Lilly\u2019s highest doses against lower doses of Novo Nordisk\u2019s medicines.<\/p>\n<p> <a href=\"https:\/\/www.theguardian.com\/business\/2026\/jul\/21\/novo-nordisk-eli-lilly-weight-loss-ads\">Continue reading&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over \u201cfalse and materially misleading\u201d adverts for its competing weight-loss and anti-diabetes treatments. The Danish pharmaceuticals heavyweight complained that the US group &#8230; <a title=\"Ozempic maker Novo Nordisk sues US rival over \u2018materially misleading\u2019 ads\" class=\"read-more\" href=\"https:\/\/news2shorts.com\/index.php\/2026\/07\/21\/ozempic-maker-novo-nordisk-sues-us-rival-over-materially-misleading-ads\/\" aria-label=\"Read more about Ozempic maker Novo Nordisk sues US rival over \u2018materially misleading\u2019 ads\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-76361","post","type-post","status-publish","format-standard","hentry","category-blog"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/76361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/comments?post=76361"}],"version-history":[{"count":0,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/76361\/revisions"}],"wp:attachment":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/media?parent=76361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/categories?post=76361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/tags?post=76361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}